JoVE Logo

Sign In

Harvard Medical School, Beth Israel Deaconess Medical Center

2 ARTICLES PUBLISHED IN JoVE

image

Medicine

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
Joshua J. Timmons 1, Sean Cohessy 2, Eric T. Wong 1
1Brain Tumor Center & Neuro-Oncology Unit, Department of Neurology, Beth Israel Deaconess Medical Center & Harvard Medical School, 2Division of Cancer Genetics, Department of Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School

Metastasis plays a profound role in the virulence of cancer, accounting for an estimated 90% of deaths. We report a protocol for a metastatic melanoma model in mice that is useful for determining the efficacy of therapeutic agents against this clinical phenomenon.

image

Cancer Research

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Mercedes M. Riley 1,2, Pyay San 1, Edwin Lok 1, Kenneth D. Swanson 1, Eric T. Wong 1
1Brain Tumor Center and Neuro-Oncology Unit, Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, 2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology

Glioblastoma is the most common and aggressive primary brain malignancy in adults, with most tumors recurring after initial treatment. Tumor Treating Fields (TTFields) therapy is the newest treatment modality for glioblastoma. Here, we describe the proper application of TTFields-transducer arrays on patients and discuss theory and aspects of treatment.

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved